glp 1 analogue market GLP-1 Agonists Report 2025-2033, By Product, Molecule, and Geo GLP-1 Receptor Agonist Market Size,

According to the Summary of Product Characteristics (SmPC), the most common side effects include: Nausea (affecting 12-24% of patients, with frequency increasing at higher doses) Diarrhoea (reported in 13-22% of participants) Vomiting (occurring in 6-10% of patients) Constipation (affecting 5-12% of users) Abdominal pain or discomfort Dyspepsia (indigestion) Decreased appetite These effects are typically mild to moderate in severity and tend to diminish over time as the body adjusts to treatment

If you want the research context first, use the GHK-Cu hub, then the deep dives for mechanism, evidence, safety and status, and quality and COA

Reference: Lee YJ et al

Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy

FIRMS & STRENGTHENS

Whether a given supplement affects something like the gut or our hormones, our skin directly, or both it can all influence breakouts